Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Cognition Therapeutics, Inc. is a biopharmaceutical company in the clinical stage, focused on identifying and advancing small molecule treatments.

52W Range

22ndpctl

Volume

0.29×avg

Market Cap

91.29MUSD

P/E Ratio

-5.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Cognition Therapeutics, Inc.

CGTXNASDAQ Global Market·USD·Closed

Cognition Therapeutics, Inc.

CGTXNASDAQ·USD·Closed

$1.02

−3.77%

$1.02

−$0.04 (3.77%)

52W Range

22ndpctl

Volume

0.29×avg

Mkt Cap

91.29MUSD

P/E

-5.3TTM

Div Yield

–ann

CGTX: Cognition Therapeutics, Inc. Stock Analysis | finqOS